Jubilant Organosys Ltd on Friday announced that it has completed the acquisition of Hollister-Stier Laboratories.
The purchase price of $122 million and the reimbursement for the capacity augmentation programme of $18.7 million has been financed through cash-on-hand from an earlier FCCB issue and also by leveraging Hollister's balance sheet.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment